Skip to main content

Amplify ETFs Announces Revised Net Asset Value Information for the Amplify Seymour Cannabis ETF (NYSE: CNBS)

Amplify ETFs announces the net asset value (NAV) of the Amplify Seymour Cannabis ETF (NYSE Arca: CNBS) was reduced by $0.2562 per share on Friday, December 6, 2019. This adjustment is a result of an error in calculating the Fund’s NAV.

Fund

 

Ticker

 

Revised NAV

(12/6/2019)

 

Original NAV

(12/6/2019)

 

Change

(%)

Amplify Seymour Cannabis ETF

 

CNBS

 

$13.20

 

$13.45

 

-1.86%

This is a one-time adjustment, and we do not expect additional changes.

For more information on CNBS, please visit CNBSETF.com.

About Amplify ETFs

Amplify ETFs, sponsored by Amplify Investments, has over $760 million in assets across its suite of ETFs (as of 11/30/2019). Amplify believes the ETF structure empowers investors through efficiency, transparency and flexibility. Since its first ETF launch in 2016, Amplify seeks to build ETFs powered by investment strategies from leading index providers and asset managers within unique market segments.

Carefully consider the Fund’s investment objectives, risk factors, charges, and expenses before investing. This and additional information can be found in the Fund’s statutory and summary prospectus, which may be obtained by calling 855-267-3837, or by visiting AmplifyETFs.com. Read the prospectus carefully before investing.

Investing involves risk, including the possible loss of principal. The Fund is new with limited operating history. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV, and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The Fund is subject to management risk because it is an actively managed.

Companies involved in the cannabis industry face competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Securities issued by non-U.S. companies present risks beyond those of securities of U.S. issuers. The Fund is non-diversified, which can cause greater share price fluctuation. For additional Fund-specific risks, please visit https://amplifyetfs.com/CNBS.

Amplify Investments LLC is the Investment Adviser to the Fund, and Penserra Capital Management, LLC serves as the Investment Sub-Adviser.

Amplify ETFs are distributed by Foreside Fund Services, LLC.

Contacts:

Sales Contact:
Amplify ETFs
855-267-3837
info@amplifyetfs.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.